 HAMILTON, BERMUDA ACCESSWIRE September 21, 2021 Altamira Therapeutics Ltd. NASDAQ:CYTO, a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection, and inner ear therapeutics, today announced that it will provide a business update on BentrioTM, its nasal spray for protection against airborne viruses and allergens, through a live conference call and webcast on Monday, September 27, 2021, at 8:00 AM Eastern Time. 